Prognostic significance of body mass index in breast cancer patients with hormone receptor-positive tumours after curative surgery

Clinical and Investigative Medicine

Volumn 36, Issue 6, 2013, Pages

  Xing, Peng ^a   Li, Ji Guang ^a   Jin, Feng ^a   Zhao, Ting Ting ^a   Liu, Qun ^a   Dong, Hui Ting ^a   Wei, Xiao Lin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; MIDDLE AGED; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

ADULT; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES;

EID: 84891587869     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Youlden DR, Cramb SM, Dunn NA, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 2012;36:237-248.
2. Wu SG, He ZY, Li Q, et al. Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients. PLoS One 2013;8:e61410.
3. Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-10874.
4. Early Breast Cancer Trialists' Collaborative Group.: Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998;351:1451-1467.
5. Brouckaert O, Paridaens R, Floris G, et al. A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative. Ann Oncol 2013;24:47-53.
6. Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. Oncologist 2004;9:606-616.
7. Kröger N, Milde-Langosch K, Riethdorf S, et al. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients. Clin Cancer Res 2006;12:159-168.
8. Masood S. Prognostic/predictive factors in breast cancer. Clin Lab Med 2005;25:809-825.
9. Rosenberg L, Czene K, Hall P. Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy?. Br J Cancer 2009;100:1486-1491.
10. Anderson GL, Neuhouser ML. Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res (Phila) 2012;5:515-521.
11. Dignam JJ, Wieand K, Johnson KA, et al. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 2003;95:1467-1476.
12. Dignam JJ, Wieand K, Johnson KA, et al. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptornegative breast cancer. Breast Cancer Res Treat 2006;97:245-254.
13. Biglia N, Peano E, Sgandurra P, et al. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women. Gynecol Endocrinol 2013;29:263-267.
14. Dawood S, Lei X, Litton JK, et al. Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer. Clin Breast Cancer 2012;12:364-372.
15. Mousa U, Onur H, Utkan G. Is obesity always a risk factor for all breast cancer patients? c-erbB2 expression is signiftcantly lower in obese patients with early stage breast cancer. Clin Transl Oncol 2012;14:923-930.
16. Borgquist S, Hjertberg M, Henningson M, et al. Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms. Breast Cancer Res Treat 2013;137:849-862.
17. Schoppmann SF, Bayer G, Aumayr K, et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 2004;240:306-312.
18. WHO/IOTF/IASO. The Asia paciftc perspective: redeftning obesity and its treatment. Hong Kong: World Health Organization, International Obesity Task Force, International Association for the Study of Obesity; 2000.
19. Choi Y, Park B, Jeong BC, et al. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer 2013;132:625-634.
20. Han X, Stevens J, Bradshaw PT. Body mass index, weight change, and survival in non-hodgkin lymphoma patients in connecticut women. Nutr Cancer 2013;65:43-50.
21. Niraula S, Ocana A, Ennis M, et al. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Treat 2012;134:769-781.
22. Demirkan B, Alacacioglu A, Yilmaz U. Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma. Jpn J Clin Oncol 2007;37:256-265.
23. Carmichael AR, Bendall S, Lockerbie L, et al. Does obesity compromise survival in women with breast cancer?. Breast 2004;13:93-96.
24. Sarkissyan M, Wu Y, Vadgama JV. Obesity is associated with breast cancer in African-American women but not Hispanic women in South Los Angeles. Cancer 2011;117:3814-3823.
25. Lu Y, Ma H, Malone KE, et al. Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J Clin Oncol 2011;29:3358-3365.
26. Tao MH, Shu XO, Ruan ZX, et al. Association of overweight with breast cancer survival. Am J Epidemiol 2006;163:101-107.
27. Giles ED, Wellberg EA, Astling DP, et al. Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer. Cancer Res 2012;72:6490-6501.
28. Gilbert CA, Slingerland JM. Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Ann Rev Med 2013;64:45-57.
29. Sparano JA, Wang M, Zhao F, et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 2012;118:5937-5946.
30. Goodwin PJ, Ennis M, Pritchard KI, et al. Insulin- and obesityrelated variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 2012;30:164-171.
31. Grossmann ME, Cleary MP. The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis. Biochimie 2012;94:2164-2171
32. Grossmann ME, Ray A, Nkhata KJ, et al. Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev 2010;29:641-653.
33. Duggan C, Irwin ML, Xiao L, et al. Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol 2011;29:32-39.
34. Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002;20:42-51.
35. Kawai M, Minami Y, Nishino Y, et al. Body mass index and survival a←er breast cancer diagnosis in Japanese women. BMC Cancer 2012;12:149.
36. Maehle BO, Tretli S, Orsen T. The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status. APMIS 2004;112:349-357.
37. Rock CL, Pande C, Flatt SW, et al. Favorable changes in serum estrogens and other biologic factors a←er weight loss in breast cancer survivors who are overweight or obese. Clin Breast Cancer 2013;13:188-195.